| 产品详情 |
| Edit |   |
| Product Name | GAD1, Recombinant, Human, aa1-224, His-Tag |
| Description | Purity ~85% (SDS-PAGE). GAD1 is one of several forms of glutamic acid decarboxylase, identified as a major autoantigen in insulin-dependent diabetes. It is responsible for catalyzing the production of gamma-aminobutyric acid from L-glutamic acid. A pathogenic role for this enzyme has been identified in the human pancreas since it has been identified as an autoantigen and an autoreactive T cell target in insulin-dependent diabetes. This protein may also play a role in the stiff man syndrome. Deficiency in this enzyme has been shown to lead to pyridoxine dependency with seizures. Alternative splicing of this gene results in two products, the predominant 67kD form and a less-frequent 25kD form. Source: Recombinant protein corresponding to aa1-224 from human GAD1, fused to His-tag at N-terminus, expressed in E.coli. Molecular Weight: ~27.7kD (247aa) Applications: Suitable for use in SDS-PAGE. |
| Size | 50ug |
| Concentration | n/a |
| Applications | n/a |
| Other Names | GAD1, Recombinant, Human, aa1-224, His-Tag (Glutamate Decarboxylase 1 Isoform GAD25, Glutamate Decarboxylase 1 (Brain, 67kD), CPSQ1, GAD, SCP) |
| Gene, Accession, CAS # | Accession: NP_038473 |
| Catalog # | 218168 |
| Price | |
| Order / More Info | GAD1, Recombinant, Human, aa1-224, His-Tag from UNITED STATES BIOLOGICAL |
| Product Specific References | n/a |
| 产品资料 |
|
|